NPPA Caps Prices on Scheduled Drugs Amid Calls for Non-Scheduled Drug Price Reforms
The National Pharmaceutical Pricing Authority (NPPA) has set ceiling prices for 935 scheduled drug formulations and retail prices for 3,845 new medicines to maintain affordability, as stated by Minister Anupriya Patel. However, a parliamentary panel criticized the limited regulation of non-scheduled drugs, which constitute 82% of the market, highlighting concerns over high mark-ups and calling for reforms to the Drugs (Prices Control) Order (DPCO) to address pricing gaps and profiteering risks.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. Coverage leans centre-right overall (Left 0%, Centre 43%, Right 57%). Overall sentiment is neutral (52/100). Lens Score 58/100.
Outlets measured: thefinancialexpress, theassamtribune. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 1 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (38–65/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
theassamtribune broke this story on 28 Jul, 11:28 am. Other outlets followed.